Blueprint Medicines Takes $40MM From Third Rock To Build Oncology Platform
This article was originally published in The Pink Sheet Daily
Executive Summary
Incubated for months within TRV, the Boston-area startup aims to discover highly specific cancer drugs for personalized medicine.